Advertisement

Topics

Search Results for "Alterna Cigs Free Trial"

21:08 EDT 20th August 2017 | BioPortfolio

Matching Channels

Free perforation

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and ...

Vitamin E

Naturally occurring vitamin E exists in eight chemical forms (alpha-, beta-, gamma-, and delta-tocopherol and alpha-, beta-, gamma-, and delta-tocotrienol) that have varying levels of biological act...

Matching News

blu Cigs President Applauds North Myrtle Beach for Eliminating E-Cigs from Smoking Ban

CHARLOTTE, N.C., Feb. 9, 2012 /PRNewswire/ -- This week, the North Myrtle Beach City Council in South Carolina passed the second and final reading of a new ordinance to regulate smoking w...

Free up sites to focus on patients, not payments!

At a conference a few months ago, I spoke with a clinical trial investigator who complained that he still received paper checks in the mail from some sponsors and CROs, often with little or no informa...

AZ buoyed by Imfinzi lung cancer trial

Phase III trial showed PD-L1 inhibitor Imfinzi increased progression-free survival

First patient treated in trial of a novel liver dialysis device, DIALIVE

(European Association for the Study of the Liver) The first patient in an international trial of a new liver dialysis system has been recruited at the Royal Free Hospital in London. The device, called...

Cancer Risk Low For Most, But Not All, E-Cigs in Modeling Study

(MedPage Today) -- Higher 'potency' tied to high levels of carbonyls

Saab completes test flight of 100% biofuel-powered Gripen aircraft

Saab's dual-seat Gripen aircraft has successfully flown using 100% biofuel made from rapeseed oil, demonstrating that alterna -More- 

Mistic E-Cigs Introduces New Cig-Alike Flavors

Mistic E-Cigs, the leading independent maker of top-selling vapor products, including mods, pods, and personal vaporizers, has introduced five new flavors for electronic cigarettes. Charlotte, North C...

Seattle Genetics and Takeda Announce Positive Results from Late-Stage NHL Trial

CAMBRIDGE, Mass., OSAKA, Japan & BOTHELL, Wash.–(BUSINESS WIRE)–Jun. 26, 2017– Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today an...

Matching PubMed Articles

E-Cigarette Topics Shared by Medical Professionals: A Comparison of Tweets from the United States and United Kingdom.

Medical professionals are now relying on social media platforms like Twitter to express their recommendations for the use or avoidance of products like electronic cigarettes (e-cigs), which may have l...

Effect of Sodium Treatment on the Performance of Electrostatic Spray Assisted Vapour Deposited Copper-poor Cu(In,Ga)(S,Se) 2 Solar Cells.

In our work, eco-friendly, non-vacuum and low cost Electrostatic Spray Assisted Vapour Deposition (ESAVD) method has been used to produce Cu(In,Ga)(S,Se)2 (CIGS) solar cells. Copper (Cu) deficient (Cu...

Gallium In-Depth Profile in Bromine- Etched Copper-Indium-Galium-(Di)selenide (CIGS) Thin Films Inspected Using Raman Spectroscopy.

In the thin film solar cells domain, copper indium galium (di)selenide (CIGS) is a material with well-established photovoltaic purpose. Here the presence of a suitable [Ga]/([Ga]+[In]) (GGI) in-depth ...

TCT-54 LEADERS FREE OAC: Biolimus A9 coated versus bare metal stents in patients requiring oral anticoagulation: A pre-specified subgroup analysis of the LEADERS FREE trial.

Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.

Given recently published results of a 750-patient adjuvant sunitinib trial showing improved disease-free survival (DFS), the appropriate strategy for treating high-risk patients is unclear. We sought ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement